Evidence map›Paper›PMID 35496820›Full record

ArticleCurrent research in immunology2022

Shared acute phase traits in effector and memory human CD8 T cells.

Silvia A Fuertes Marraco, Daniel Alpern, Sébastien Lofek, Joao Lourenco, Amandine Bovay, Hélène Maby-El Hajjami, Mauro Delorenzi, Bart Deplancke, Daniel E Speiser

Open access · goldAbstract read
In one paragraph

Article in Current research in immunology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.2field-weighted citation impact, top 48% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 3 citations in OpenAlex.

  1. Frontiers in immunology · 2023
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 1 country.

Silvia A Fuertes MarracoDepartment of Oncology, Lausanne University Hospital and University of Lausanne, Epalinges, Switzerland.
Daniel AlpernLaboratory of Systems Biology and Genetics, Institute of Bioengineering, School of Life Sciences, Ecole Polytechnique Fédérale de Lausanne (EPFL) and Swiss Institute of Bioinformatics, Lausanne, Switzerland.
Sébastien LofekDepartment of Oncology, Lausanne University Hospital and University of Lausanne, Epalinges, Switzerland.
Joao LourencoBioinformatics Core Facility, SIB Swiss Institute of Bioinformatics, Lausanne, Switzerland.
Amandine BovayDepartment of Oncology, Lausanne University Hospital and University of Lausanne, Epalinges, Switzerland.
Hélène Maby-El HajjamiDepartment of Oncology, Lausanne University Hospital and University of Lausanne, Epalinges, Switzerland.
Mauro DelorenziDepartment of Oncology, Lausanne University Hospital and University of Lausanne, Epalinges, Switzerland.
Bart DeplanckeLaboratory of Systems Biology and Genetics, Institute of Bioengineering, School of Life Sciences, Ecole Polytechnique Fédérale de Lausanne (EPFL) and Swiss Institute of Bioinformatics, Lausanne, Switzerland.
Daniel E SpeiserDepartment of Oncology, Lausanne University Hospital and University of Lausanne, Epalinges, Switzerland.
University of Lausanne · CHSIB Swiss Institute of Bioinformatics · CH

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

CD8 T cells have multiple functional properties that mediate acute phase and long-term immune protection. Several effector and memory CD8 T cell subsets have been described with diverse functionalities and marker profiles. In contrast to the many comprehensive mouse studies, most human studies lack samples from the acute infection phase, a major reason why current knowledge of human T cell subsets and differentiation remains incomplete, particularly with regard to the T cell heterogeneity early during the immune response. Here we analysed the human CD8 T cell response to yellow fever vaccination as the best-known model to study the human immune response to acute viral infection. We performed flow cytometry on 21 markers conventionally used in mice and in humans to describe differentiation, activation, cycling, and so-called effector functions. We found clearly distinct 'acute traits' at the peak of the response that are shared amongst all non-naïve antigen-specific subsets, including memory-differentiated cells. These acute traits were low BCL-2 and high KI67, CD38, HLA-DR, as well as increased Granzyme B and Perforin, previously attributed only to effector cells at the peak of the response. Furthermore, analysis of chromatin accessibility at the single cell level revealed that memory- and effector-differentiated cells clustered together specifically in the acute phase. Altogether, we demonstrate 'acute traits' across differentiation subsets, and point out the need to discriminate the differentiation states when studying human CD8 T cells that undergo an acute response.

Indexed as

Acute traitsEffectorHuman CD8 T cellsMemoryYF-17D vaccination

Identifiers

PMID35496820
PMCPMC9040096
OpenAlexW4200002970

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.